Waystar Considers Sale Amid Falling Market Value and Industry Shifts
Healthcare software firm Waystar is exploring a potential sale, two years after going public, as its market value declines.
Waystar, a prominent healthcare software provider, is reportedly considering various strategic options, including a potential sale, according to sources familiar with the matter. The company, known for its technology that streamlines administrative tasks for hospitals and doctors, may be seeking to revert to private ownership just two years after its public market debut in New York.
Investment Bank Evercore Advises on Potential Sale
Sources indicate that Waystar has engaged investment bank Evercore to oversee the exploratory process, which remains in its preliminary stages. While the possibility of a sale is being considered, insiders caution that plans remain fluid and may not ultimately result in a transaction.
Waystar's decision comes amid a challenging period for the software sector, with the company's market valuation dropping to approximately $4.8 billion. This decline follows a 24% decrease in its share price over the year, reflecting broader market trends affecting technology stocks.
Market Dynamics and Investor Sentiment
Initially, Waystar positioned itself as a technology company, aiming to capitalize on higher valuations typical of the tech industry. This strategy was successful in the short term, with shares peaking at $45 in 2025, up from $20 at the time of its stock market entry. However, investor confidence has waned amid concerns about the potential impact of advancements in artificial intelligence on traditional software companies.
The company's largest shareholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and BlackRock Institutional Trust Company. EQT, the primary stakeholder with a 13% share, along with other major investors, has yet to comment publicly on the potential sale discussions.
Background and Industry Context
Waystar was established in 2017 through the merger of Zirmed and Navicure, both of which were involved in healthcare revenue management. The firm has since focused on developing software solutions that automate administrative functions within the healthcare sector, distinguishing itself from more labor-intensive service models.
The potential sale could serve as an indicator of the current appetite for investments in software companies, particularly those serving the healthcare industry. As the market continues to evolve, Waystar's exploration of strategic alternatives underscores the ongoing pressures and opportunities faced by technology firms in navigating investor expectations and technological advancements.